The MYV stem

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> PRODUCTS

The MYV stem

Products	The MYV stem
Company	Protetim Medical Instrument Makers Ltd.
Item	The MYV stem
Features	The CD angle of the stem is 132. The stem is designed to match the shape of the medullary cavity of the femur. It ensures excellent primary stability, which may be further increased by applying bone cement.
Description	The cemented hip joint prosthesis system.
Info	Protetim Medical Instrument Makers Ltd. Customer Service: +36-62-241-609 Web site: http://www.protetim.hu

Related medicine products :

1. OnePort™ Disposable Bladed/Shielded Trocars w/ Ribbed Cannula
2. Disposable Dilating Trocars w/ Ribbed Cannula
3. OnePort™ Multi-use Ribbed Titanium Cannulas

TAG: The MYV stem

Medicine Products:

Full Handle Laseredge Implant Blade Knife, 6.0 pilot tip Full Handle Laseredge Implant Blade Knife, 3.2 mm round tip Full Handle Laseredge Implant Blade Knife, 5.2 mm straight Full Handle Laseredge Crescent Blade Knife, angled bevel down

Breaking Medicine News(10 mins):Health News:Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts 2 Health News:Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts 3 Health News:Are manometric findings different between the patients with erosive and nonerosive disease? 2 Health News:Custom Health Plans Revamps Web site and Launches Blog to Help Consumers Find the Best Options for Affordable Health Insurance 2 Health News:Selenium, Omega-3s May Stave Off Colorectal Cancer 2 Health News:Selenium, Omega-3s May Stave Off Colorectal Cancer 3 Health News:Selenium, Omega-3s May Stave Off Colorectal Cancer 4 Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 2 Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 3 Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 4 Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 5

[0] Save Flexible Spending Plans Applauds Amendment to Protect Flexible Spending Accounts [0] Are manometric findings different between the patients with erosive and nonerosive disease?[0] Custom Health Plans Revamps Web site and Launches Blog to Help Consumers Find the Best Options for Affordable Health Insurance [0] Selenium, Omega-3s May Stave Off Colorectal Cancer [0] LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference

Other Medicine News:Health News:Apollo Hospitals Short-listed to Provide Diagnostics in the UK 2 Health News:Teenage Mental Problems Could Be The Result Of Stress During Early Life 2 Health News:Diet Effective In Curing Diabetes 2

Tea Found To Boost Insulin Production And Prevent Cataract,Apollo Hospitals Short-listed to Provide Diagnostics in the UK Teenage Mental Problems Could Be The Result Of Stress During Early Life Cancer Causing Proteins Trigger Abnormal Biochemical Reactions In Cells Meta Analysis Links Diabetes And Colorectal Cancer Diet Effective In Curing Diabetes

Breaking Medicine Technology:Elsevier Selects BrainTrack Directory as Supplier of College Data 2 Elsevier Selects BrainTrack Directory as Supplier of College Data 3 Elsevier Selects BrainTrack Directory as Supplier of College Data 4 AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays 2 Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R) 2 Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 1 Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 2 Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 3 Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 4 Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 5 Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 6 Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 1 Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 2 Alere Executives Present National Health Improvement Strategy to Congressional and Industry Leaders 47747 3 Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 1 Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 2 Gene Network Sciences Announces Cancer Collaboration with University of Connecticut Health Centers Neag Comprehensive Cancer Center 47744 3

[0] Elsevier Selects BrainTrack Directory as Supplier of College Data [0] AstraZeneca Medicare Part D Patient Assistance Program No Longer Requires Co-Pays [0] Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)